Southern Nevada Spring Chapter Program

Join us for a complimentary educational event this spring, where you can network with colleagues, share a meal, earn CE contact hours, and learn more about PCNA—hosted by the Southern Nevada Chapter.

PCNA members and non-members are welcome to register and attend this free event. Please share this with colleagues and friends.

Thank you to our sponsor Merck.

Agenda

12:00	Registration, Chapter Meeting and Lunch
12:30	Addressing Risk of HF Rehospitalization With an Additional Guideline-Recommended Medication presented by Merck (non-CE)
1:30	Nurse Health and Wellness (1.0 CE)
2:30	Questions and Answers (0.5 CE)
3:00	Endocarditis related to IVDU (1.0 CE)
4:00	Questions and Answers (0.5 CE)
4:30	Closing

Presentation Topics

Endocarditis Related to IVDU (1.0 CE contact hours)

Learning Objectives

• Describe Cardiac anatomy, definition of endocarditis, types of endocarditis (right sided and left sided), risk factors, epidemiology (will focus more on IV drug users and Intravascular Devices).
• Summarize pathophysiology, most common pathogens (microbiology), clinical manifestations, complications.
• Identify radiographic findings and laboratory of infective endocarditis.
• Explain the management of antibiotic therapy, surgical assessment, outcomes, and patient education.

Nurse Health and Well-Being (1.0 CE contact hours)

Learning Objectives

• Identify the physical health concerns found to be prominent in the nursing population.
• Review the impact of burnout, current workforce issues and stress on the mental health of nurses.
• Discuss occupational health safety including variations and methods to leverage employer wellness programs and workplace environment issues to promote healthy lifestyles and health attainment by nurse employees.
• Explore best practices and innovation in self-care and health promotion of the nursing workforce.

Addressing Risk of HF Rehospitalization With an Additional Guideline-Recommended Medication presented by Merck (non-CE)

Learning Objectives

• Discuss the increased risk of rehospitalization for HF with additional HFH
• Review an outcome study in high-risk patients with HFrEF